iStock, Zolak President Donald Trump is considering tariff exemptions for certain “non-patented” pharmaceuticals, though the White House has yet to release specific guidelines. The White House may exempt certain pharmaceutical imports from its reciprocal tariff scheme, with an eye toward helping “satisfy domestic demand.” In an executive order last Friday, President Donald Trump insisted that he is “generally unwilling” to limit the scope of reciprocal tariffs “before the conclusion of a fina

iStock, Michael Vi The settlement agreement will extend market exclusivity for AbbVie’s JAK inhibitor in the U.S. until 2037—providing pediatric exclusivity is granted. AbbVie has reached a settlement with generic drugmakers, extending the period of exclusivity for its JAK inhibitor Rinvoq to 2037. The deal extends Rinvoq’s exclusivity another four years. In an SEC filing on Thursday, the pharma revealed that it has settled lawsuits with “all” generic manufacturers seeking to bring their cop

SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced the pricing of its upsized underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $40.00 per share. All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, b

We see an uptick in patients during the fall. The warmer temperatures allow for a longer growing season. This means that more pollen gets released into the air, causing allergies to spike.” — Dr. Lindsey McMullan, Mississippi Asthma & Allergy Clinic JACKSON, MS, UNITED STATES, September 11, 2025 / EINPresswire.com / -- Mississippi doctors are preparing for fall allergy season as autumn approaches. Allergy season is starting earlier and lasting longer than in the past. This longer season is due

CENTER VALLEY, Pa., Sept. 11, 2025 /PRNewswire/ -- During National Prostate Health Month in September, Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience and outcomes for men suffering from symptoms associated with benign prostatic hyperplasia (BPH), known as enlarged prostate. Continue Reading Inaugural iTind Center of Excellence members are, from left, Dr. C. Cragin Anderson, Dr. Petar Bajic, and D

SACRAMENTO, Calif., Sept. 11, 2025 /PRNewswire/ -- Sophont, a medical AI startup, announced the closing of its $9.22M pre-seed and seed funding round led by Kindred Ventures, with participation from Upfront Ventures, Delphi Ventures, Jeff Dean (Google DeepMind), Logan Kilpatrick (Google DeepMind), Lukas Biewald (Weights & Biases), Clément Delangue (Factorial Capital, Hugging Face), and other investors. Continue Reading Paul Scotti (CTO) and Tanishq Abraham (CEO) Sophont is building multimodal m

Over-the-Counter Drug Research Evaluation of Sunscreen Active Ingredients DARS has conducted two randomized clinical trials which demonstrated systemic exposure of multiple commonly used sunscreen active ingredients under single and maximal use conditions. Additionally, DARS is evaluating in vitro metabolism and transporter-based drug interactions with sunscreen active ingredients. The clinical effect of these findings is unknown and continued use of sunscreen is encouraged. Publications Abbasi

Renewed provider agreement makes Chartwell the exclusive provider for Medical Assistance Fee-For-Service Beneficiaries. This designation reaffirms our commitment to improving patient access to specialty pharmacy treatments, supporting positive therapy outcomes, and delivering excellent care to our patient population.” — Kathie Patrick, President, Chartwell Pharmacy PITTSBURGH, PA, UNITED STATES, September 11, 2025 / EINPresswire.com / -- Chartwell Pharmacy , one of the largest and most clinicall

A Serious Medication-Induced Disorder Linked to Suicide Demands Clinician Training and Public Awareness Safe medication practices are crucial, since this disorder is often linked to medication-induced suicidality and suicide.” — Wendy Dolin, MISSD Founder CHICAGO, IL, UNITED STATES, September 11, 2025 / EINPresswire.com / -- Yesterday was World Suicide Prevention Day, when organizations across the globe spotlighted suicide prevention strategies. Yet one critical reality received little attention

NexGen Health in San Jose has launched a physician-led Cerebrolysin IV Therapy Program, offering advanced neurological support through a personalized 10-treatment protocol. Designed to aid patients with stroke, traumatic brain injury, cognitive decline, and neurodegenerative diseases, this science-backed therapy enhances neuroplasticity, reduces inflammation, and supports long-term brain health. SAN JOSE, Calif., Sept. 11, 2025 /PRNewswire/ -- NexGen Health, a physician-led regenerative and func